±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 635  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

ÖÜÑÇéª0623

½ð³æ (³õÈëÎÄ̳)

[ÇóÖú] ¼±Çó½«Õâ¶Î·­ÒëΪÖÐÎÄ

A preliminary vaginal pharmacokinetics study was carried out to monitor drug substance in blood plasma. LC¨CMS/MS assay using positive ion electro-spray ionization (ESI) in multiple reaction monitoring (MRM) mode was found appropriate to develop selective, sensitive and reproducible analysis of compound 33, N-9 and internal standard (IS) in rabbit plasma. The pharmacokinetic analysis was processed non-compartmental model using Phoenix Win-Nonlin (version 6.3, Pharsight, MountainView, CA). The linear trapezoidal method with linear interpolation was used to calculate pharmacokinetic parameters. The mean peak plasma concentration ( Cmax) 4.87 ¡À 0.37 ng/mL of N-9 was achieved after vaginal dosing at 1.0 h. The terminal half-life of plasma concentration of N-9 was 1.45 ¡À 0.07 h. The systemic absorption of compound33 was below the limit of quantitation (Fig. 5). After vaginal administration, the presence of compound 33was very less in systemic circulation might be suggestive of minimal systemic adverse effects or minimal toxic effect. In summary, together with pharmacological findings, this study could provide useful clues and guidance,such as dosage regimen and application strategy of compound 33 as a lead candidate to be used as vaginal microbicide. In a systemic effort to identify a non-detergent prophylactic vaginal microbicide potentially capable of preventing sexual transmission of HIV/STDs as well as providing fertility control, a series of dithiocarbamate¨Cthiourea hybrids as alkyl 4-(alkyl/aryl carbamothioyl)piperazine-1-carbodithioate (14¨C38 ) were synthesized and evaluated for multiple activities (anti- Trichomonas, spermicidal and RT inhibition). The intended dual action was achieved and several compounds exhibited all the three activities with remarkable safety against cervico-vaginal epithelial cells and vaginal flora. Among the safest structures, most promising compound33 exhibited considerable RT inhibition, anti- Trichomonas and spermicidal activities, which could be attributed to its utility as vaginal microbicide. Proposed docking analysis of 33 is notable and can be utilized as a guideline for designing of promising vaginal microbicide with RT inhibition potential. Compound 33 was also found pharmacokinetically safe in comparison to N-9 due to least vaginal absorption to systemic circulation. Further lead optimization is underway to develop novel vaginal microbicide possessing RT inhibitory activity in order to empower women to deal independently with their reproductive health and fertility.

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Î人һÐÄÒ»Òë

¾èÖú¹ó±ö (ÖøÃûдÊÖ)


¡¾´ð°¸¡¿Ó¦Öú»ØÌû

É̼ÒÒѾ­Ö÷¶¯ÉùÃ÷´Ë»ØÌû¿ÉÄܺ¬ÓÐÐû´«ÄÚÈÝ
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ...
ÖÜÑÇéª0623: ½ð±Ò+60, ·­ÒëEPI+1, ¡ï¡ï¡ïºÜÓаïÖú 2015-05-16 13:24:45
ÄÚÈÝÒÑɾ³ý
2Â¥2015-05-16 10:22:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÖÜÑÇéª0623 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ£¬³õÊԳɼ¨350Çóµ÷¼Á +9 ÑØ°¶?±´¿Ç 2026-04-04 14/700 2026-04-05 01:09 by ÑØ°¶?±´¿Ç
[¿¼ÑÐ] ²ÄÁÏÇóµ÷¼Á +10 ÄØÄØÄÝÄÝ 2026-04-01 10/500 2026-04-04 23:12 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] »¯Ñ§357·Ö£¬¿¼Ñе÷¼Á +8 .Starry. 2026-04-04 9/450 2026-04-04 22:52 by ÀíÏëÔÚʵ¼ùÖ®ÖÐ
[¿¼ÑÐ] 0703×Ü·Ö331Çóµ÷¼Á +9 ZY-05 2026-04-04 12/600 2026-04-04 22:10 by ZY-05
[¿¼ÑÐ] 085404×Ü·Ö289£¬Çóµ÷¼Á +4 Acesczlo 2026-03-29 4/200 2026-04-04 21:43 by hemengdong
[¿¼ÑÐ] µ÷¼Á +4 ÊÇ¿ÉÀÖ²»ÊÇ¿ÉÀÖ 2026-04-04 4/200 2026-04-04 19:41 by ÌÆãå¶ù
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358 +6 cs0106 2026-04-03 6/300 2026-04-04 11:20 by w_xuqing
[¿¼ÑÐ] 288Çóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó ²ÄÁÏÓ뻯¹¤ +12 ÂåÉñ¸ç¸ç 2026-04-03 12/600 2026-04-04 09:22 by ÓлúСÃñ¹¤
[¿¼ÑÐ] ²ÄÁÏר˶µ÷¼Á +18 Ò¬Ò¬¡£ 2026-03-29 18/900 2026-04-03 16:45 by ÁáÁá0606
[¿¼ÑÐ] ¿¼Ñе÷¼Á +8 ²»°®ºÈÒûÁÏ 2026-04-03 8/400 2026-04-03 16:40 by Mistake-J
[¿¼ÑÐ] µ÷¼ÁÇóÖú +8 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-02 11/550 2026-04-03 14:16 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] ¹¤¿Æ 267Çóµ÷¼Á +5 wanwan00 2026-04-02 7/350 2026-04-03 14:14 by zhangdingwa
[»ù½ðÉêÇë] ÇëÎʹ²Í¬Í¨Ñ¶ºÍ¹²Í¬Ò»×÷µÄÈϿɶÈÎÊÌâ 10+4 psa1234 2026-04-01 10/500 2026-04-03 11:08 by Kittylucky
[¿¼ÑÐ] 0856²ÄÁÏÓ뻯¹¤µ÷¼Á£¬339 +14 10213207 2026-03-31 14/700 2026-04-02 21:01 by 1104338198
[¿¼ÑÐ] 303·Ö 0807ѧ˶Çóµ÷¼Á +3 TYC3632 2026-04-01 3/150 2026-04-01 19:24 by lwk2004
[¿¼ÑÐ] 085410È˹¤ÖÇÄÜ ³õÊÔ316·Ö Çóµ÷¼Á +3 ²ÐÐÇ·÷Êï 2026-03-31 3/150 2026-04-01 11:09 by СÐÜraider
[¿¼ÑÐ] 318Çóµ÷¼Á +8 ÆßÒä77 2026-04-01 8/400 2026-04-01 10:37 by Jaylen.
[¿¼ÑÐ] Çóµ÷¼Á +8 11ggg 2026-03-30 8/400 2026-03-31 13:56 by nanaliuyun
[¿¼ÑÐ] 276Çóµ÷¼Á +3 ÕԾûª 2026-03-29 3/150 2026-03-31 10:06 by cal0306
[¿¼ÑÐ] Çóµ÷¼Á +7 Çà´º²ÃΪÈý½Ø 2026-03-29 7/350 2026-03-30 13:14 by laoshidan
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û